Researchers have developed PRECEDE, an AI system designed to assist in drug redesign by focusing on mitigating side effects while maintaining therapeutic efficacy. This system operates as a co-scientist, utilizing evidence-based reasoning over drug-side-effect associations, biomedical knowledge graphs, and safety-driven optimization precedents. PRECEDE is structured as a human-supervised workflow, ensuring that hypotheses are auditable, falsifiable, and grounded in existing pharmacological knowledge. AI
IMPACT Could accelerate the development of safer and more effective pharmaceuticals by improving the drug redesign process.
RANK_REASON Research paper detailing a novel AI system for drug redesign. [lever_c_demoted from research: ic=1 ai=1.0]
- alphaXiv
- arXiv
- CatalyzeX Code Finder for Papers
- Connected Papers
- CORE Recommender
- DagsHub
- Gotit.pub
- Hugging Face
- IArxiv Recommender
- Litmaps
- ScienceCast
- scite Smart Citations
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →